Efficacy of single-dose ceftriaxone in experimental otitis media induced by penicillin- and cephalosporin-resistant Streptococcus pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 9, 1996, Pages 1977-1982

  Barry, Beatrix ^a   Muffat Joly, Martine ^a   Bauchet, Jacqueline ^a   Faurisson, François ^a   Gehanno, Pierre ^a   Pocidalo, Jean Jacques ^a   Carbon, Claude ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFTRIAXONE;

ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT; CEREBROSPINAL FLUID; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG ELIMINATION; FEMALE; GERBIL; MIDDLE EAR; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OTITIS MEDIA; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029815153     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.9.1977     Document Type: Article

References (39)

1. Albertini, M., R. Garraffo, H. B. Drageon, R. Mariani, and P. Lapalus. 1992. Pharmacokinetics and bactericidal activity of i.v. ceftriaxone administered to children as a single daily infusion of 50 mg/kg. Int. J. Exp. Clin. Chemother. 5:125-133.
2. Azoulay-Dupuis, E., V. Rieux, C. Sauve, C. Rivier, and E. Vallée. 1995. Killing of penicillin and cefotaxime-resistant Streptococcus pneumoniae strains by some β-lactams and a glycopeptide according to tolerance of the strains, abstr. 2231. Final program and abstracts of the 19th International Conference of Chemotherapy. Can. J. Infect. Dis. 6(Suppl. C):381C.
3. Baquero, F., and E. Loza. 1994. Antibiotic resistance of microorganisms involved in ear, nose and throat infections. Pediatr. Infect. Dis. J. 13(Suppl. 1):S9-S14.
4. Barnett, E. D., J. O. Klein, D. W. Teele, H. Cabral, S. I. Pelton, S. Kharasch, V. Pires, S. Starobin, G. Fisch, and R. Heppen. 1994. Single dose ceftriaxone for acute otitis media, abstr. M26, p. 219. In Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
5. Barry, A. L., S. D. Brown, and W. J. Novick. 1995. In vitro activities of cefotaxime, ceftriaxone, ceftazidime, cefpirome, and penicillin against Streptococcus pneumoniae isolates. Antimicrob. Agents Chemother. 39:2193-2196.
6. Barry, B., M. Muffat-Joly, J. Bauchet, P. Genanno, J. J. Pocidalo, and C. Carbon. 1995. Efficacy of single dose ceftriaxone in experimental middle ear otitis induced by penicillin- and cephalosporin-resistant Streptococcus pneumoniae, abstr. 2099. Final program and abstracts of the 19th International Conference of Chemotherapy. Can. J. Infect. Dis. 6(Suppl. C):359C
7. Barry, B., M. Muffat-Joly, P. Gehanno, and J. J. Pocidalo. 1993. Effect of increased dosage of amoxicillin in the treatment of experimental middle ear otitis due to penicillin-resistant Streptococcus pneumoniae. Antimicrob. Agents Chemother. 37:1599-1603.
8. Barry, B., M. Muffat-Joly, P, Gehanno, and J. J. Pocidalo. 1995. Pathogenicity and meningeal spread of Streptococcus pneumoniae serotype 19 and 23 with varying susceptibility to penicillin in experimental acute otitis media. In D. J. Lim, C. D. Bluestone, J. O. Klein, et al. (ed.), Recent advances in otitis media - proceedings of the Sixth International Symposium, in press. Decker Periodicals Publishing, Hamilton, Ontario, Canada.
9. Block, S. L., J. A. Hedrick, R. D. Tyler, and R. A. Smith. 1994. Penicilin-resistant S. pneumoniae in acute otitis media in healthy children, abstr. M64, p. 260. In Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
10. Bradley, J. S., L. S. Compogiannis, W. E. Murray, M. A. Acosta, and G. L. Tsu. 1992. Pharmacokinetics and safety of intramuscular injection of concentrated ceftriaxone in children. Clin. Pharm. 11:871-873.
11. Bradley, J. S., and J. D. Connor. 1991. Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics. Pediatr. Infect. Dis. J. 10:662-666.
12. Catalàn, M. J., J. M. Fernàndez, A. Vasquez, E. Varela de Seijas, A. Suàrez, and J. C. L. Bernaldo de Quiros. 1994. Failure of cefotaxime in the treatment of meningitis due to relatively resistant Streptococcus pneumoniae. Clin. Infect. Dis. 18:766-769.
13. Cleveland, K. O. M. G. Threlkeld, F. C. Tenover, and R. J. Leggiadro. 1995. Drug-resistant pneumococcal meningitis in an American adult. Clin. Infect. Dis. 20:1572-1573.
14. Dagan, R., O. Abramson, E. Leibovitz, R. Lang, S. Goshen, D. Greenberg, P. Yagupsky, A. Leiberman, and D. M. Fliss. 1995. Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by intermediately penicillin-resistant pneumococci, abstr. LB-25, p. 12. In Program Addendum of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
15. Del Rio, M., G. H. McCracken, Jr., J. D. Nelson, D. Chrane, and S. Shelton. 1982. Pharmacokinetics and cerebrospinal fluid bactericidal activity of ceftriaxone in the treatment of pediatric patients with bacterial meningitis. Antimicrob. Agents Chemother. 22:622-627.
16. European Community. 1986. Journal officiel des communautés européennes, 18 décembre. Report L358. Office des publications officielles des communautés européennes, Luxembourg.
17. Figueiredo, A. M. S., J. D. Connor, A. Severin, M. V. Vaz Pato, and A. Tomasz. 1992. A pneumococcal clinical isolate with high-level resistance to cefotaxime and ceftriaxone. Antimicrob. Agents Chemother. 36:886-889.
18. Fraschini, F., P. C. Braga, G. Scarpazza, F. Scaglione, O. Pignataro, G. Sambataro, C. Mariani, G. C. Roviaro, F. Varoli, and G. Esposti. 1986. Human pharmacokinetics and distribution in various tissues of ceftriaxone. Chemotherapy (Basel) 32:192-199.
19. Friedland, I. R., S. Shelton, M. Paris, S. Rinderknecht, S. Ehrett, K. Krisher, and G. H. McCracken. 1993. Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr. Infect. Dis. J. 12:196-200.
20. Fulghum, R. S., J. E. Brinn, A. M. Smith, H. J. Daniel, and P. J. Loesche. 1982. Experimental otitis media in gerbils and chinchillas with Streptococcus pneumoniae, Haemophilus influenzae, and other aerobic and anaerobic bacteria. Infect. Immun. 36:802-810.
21. Gehanno, P., G. Lenoir, and P. Berche. 1995. In vivo correlates for Streptococcus pneumoniae penicillin resistance in acute otitis media. Antimicrob. Agents Chemother 39:271-272.
22. Geslin, P., S. Spicq, G. Georges, G. Sissia, and A. Fremaux. 1995. Sensibilité au cefotaxime de 2472 souches de S. pneumoniae isolées en France de novembre 1994 à avril 1995, abstr. 172, p. 159. In Abstracts of the 15e Réunion Interdisciplinaire de Chimiotherapie Anti-Infectieuse. Société Française de Microbiologie, Paris, France.
23. Giebink, G. S., G. Schiffman, K. Petty, and P. G. Quie. 1978. Modification of otitis media following vaccination with the capsular polysaccharide of Streptococcus pneumoniae in chinchillas. J. Infect. Dis. 138:480-487.
24. Green, S. M., and S. G. Rothrock. 1993. Single-dose intramuscular ceftriaxone for acute otitis media in children. Pediatrics 91:23-30.
25. Iliadis, A., A. C. Brown, and M. L. Huggins. 1992. APIS: a software for model identification, simulation and dosage regimen calculations in clinical and experimental pharmacokinetics. Comp. Methods Prog. Biomed. 38:227-239.
26. John, C. C. 1994. Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review. Clin. Infect. Dis. 18:188-193.
27. Martin, E., J. R. Koup, U. Paravicini, and K. Stoeckel. 1984. Pharmacokinetics of ceftriaxone in neonates and infants with meningitis. J. Pediatr. 105:475-481.
28. Moine, P., E. Vallée, E. Azoulay-Dupuis, P. Bourget, J. P. Bédos, J. Bauchet, and J. J. Pocidalo. 1994. In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model. Antimicrob. Agents Chemother. 38:1953-1958.
29. Routledge, P. A. 1994. Pharmacokinetics in children. J. Antimicrob. Chemother. 34(Suppl. A):19-24.
30. Ruuskanen, O., and T. Heikkinen. 1994. Otitis media: etiology and diagnosis Pediatr. Infect. Dis. J. 13(Suppl. 1):S23-S26.
31. Schaad, U. B., and K. Stoeckel. 1982 Single-dose pharmacakinetics of ceftriaxone in infants and young children. Antimicrob. Agents Chemother. 21: 248-253.
32. Scully, B. E., K. P. Fu, and H. C. Neu. 1984. Pharmacokinetics of ceftriaxone after intravenous infusion and intramuscular injection. Am. J. Med. 77 (Suppl. 4C):112-116.
33. Sloas, M. M., F. F. Barrett, P. J. Chesney, B. K. English, B. C. Hill, F. C. Tenover, and R. J. Leggiadro. 1992. Cephalosporin treatment failure in penicillin- and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr. Infect. Dis. J. 11:662-666.
34. Steele, R. W., L. B. Eyre, R. W. Bradsher, R. E. Weinfeld, I. H. Patel, and J. Spicehandler. 1983. Pharmacokinetics of ceftriaxone in pediatric patients with meningitis. Antimicrob. Agents Chemother. 23:191-194.
35. Stoeckel, K., P. J. McNamara, R. Brandt, H. Plozza-Nottebrock, and W. H. Ziegler. 1981. Effect of concentration-dependent plasma protein binding on ceftriaxone kinetics. Clin. Pharmacol. Ther. 29:650-657.
36. Thornsberry, P., P. H. Burton, and B. H. Vanderhoof. 1995. Increasing Resistance to third-generation cephalosporins in Streptococcus pneumoniae: a 1995 surveillance study in the United States, abstr. LB-24, p. 12. In Program Addendum of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
37. Trautmann, K. H., and P. Haefelfinger. 1981. Determination of the cephalosporin Ro 13-9904 in plasma, urine and bile by means of ion-pair reversed phase chromatography. High Resolut. Chromatogr. Commun. 4:54-59.
38. Varsano, I., M. Frydman, J. Amir, and G. Alpert. 1988. Single intramuscular dose of ceftriaxone as compared to 7-day amoxicillin therapy for acute otitis media in children. Chemotherapy (Basel) 34(Suppl. 1):39-46.
39. Varsano, I., B. Volovitz, Z. Horev, A. Cohen, N. Eilam, O. Shpeizer, and J. Amir. 1994. Single I.M. dose of ceftriaxone compared to ten days amoxicillin-clavulanate augmentin for therapy of acute otitis media in children, abstr. 1059, p. 333. In Abstract book of the 6th International Congress for Infectious Diseases. International Society for Infectious Diseases, Boston.